Update

Single shot in 'tiny coffee cups’ could deliver multiple vaccines, MIT

By Dan Stanton contact

- Last updated on GMT

The PLGA microstructires resemble coffee cups containing APIs or vaccines for delayed delivery. Image: Courtesy of the Langer lab
The PLGA microstructires resemble coffee cups containing APIs or vaccines for delayed delivery. Image: Courtesy of the Langer lab
3-D microparticles which degrade at differing rates in the body could allow multiple doses of drugs or vaccines to be administered in a single injection, say MIT researchers.

The research, funded by the Bill and Melinda Gates Foundation, has led to the creation of a 3-D fabrication method for microstructures made from the biocompatible polymer PLGA – already approved in medical devices such as implants and prosthetics.

These structures “resemble tiny coffee cups that can be filled with a drug or vaccine and then sealed with a lid,”​ according to the team from Massachusetts Institute of Technology (MIT) and, due to the nature of the polymer, degrade at explicit times administering (or ‘lifting the lid and spilling’) the API or vaccine to the patient.

"They can be injected subcutaneously or intramuscularly (IM) and remain at the injected location  due to their micron size,"​ Ana Jaklenec, a research scientist at MIT’s Koch Institute for Integrative Cancer Research and a senior author on the paper published on the research, told us.

Single injection

The concept has the potential to deliver multiple doses of a drug, or even a full vaccination regimen into the patient through a single injection.

“For the first time we can create a library of tiny, encased vaccine particles, each programmed to release at a precise, predictable time, so that people could potentially receive a single injection that, in effect, would have multiple boosters already built into it,”drug delivery pioneer​ Robert Langer from the David H. Koch Institute Professor at MIT said.

This could be particularly of interest in the developing world, where visits to a doctor are limited. A child could theoretically receive all his or her vaccines and booster shots through one injection.

SEAL technology

The microstructures are made using MIT’s SEAL (StampEd Assembly of polymer Layers) technology platform, drawn from computer chip manufacturing.

Silicon moulds for the cups and the lids were created using photolithography and a custom-built, automated dispensing system employed to fill the cups with API or vaccines. The lids are then slightly heated and fused on.

“Each layer is first fabricated on its own, and then they’re assembled together,”​ Jaklenec said. “Part of the novelty is really in how we align and seal the layers. In doing so we developed a new method that can make structures which current 3-D printing methods cannot.”

She added the method of manufacture can be used with any thermoplastic material and could have broad applications for injectable pulsatile drug delivery, pH sensors, and 3-D microfluidic devices, for example.

And according to Jaklenec, MIT is in discussion with several pharmaceutical companies regarding scale up and further development of this technology.

"We are working with several commercial and R&D vaccines to show efficacy of our single injection micro-cups.  Additionally, we are looking to set up a manufacturing facility so that we can move as fast as possible to get to human trials,"​ she told us.

Related news

Show more

Related products

show more

Roquette Oral Dose Case Study - Part IV

Roquette Oral Dose Case Study - Part IV

Roquette Pharma Solutions | 04-Dec-2017 | Case Study

Download the latest Roquette case study and learn more on how PEARLITOL® Flash mannitol and starch compound offers inert stability, fast disintegration...

Roquette Oral Dose Case Study - Part III

Roquette Oral Dose Case Study - Part III

Roquette Pharma Solutions | 27-Nov-2017 | Case Study

Download the Case Study to find out how Roquette’s SweetPearl® P 300 DC maltitol technology makes an effervescent tablet solution attractive and palatable...

The Solid Dose, Latest News from Colorcon

The Solid Dose, Latest News from Colorcon

Colorcon Inc. | 06-Nov-2017 | Data Sheet

With a commitment to serve customers through product innovation and technical excellence, Colorcon's Solid Dose newsletter brings you the latest insight...

Roquette Oral Dose Case Study - Part II

Roquette Oral Dose Case Study - Part II

Roquette Pharma Solutions | 06-Nov-2017 | Case Study

Download the case study and learn more on how Roquette’s taste masking technology KLEPTOSE® Linecaps (KL) allows the delivery of an efficient taste masking...

Related suppliers

Follow us

Products

View more

Webinars